Monoclonal antibody NKY13

Chemistry: molecular biology and microbiology – Spore forming or isolating process

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530327, 435 7021, 4351722, C12N 520, C12N 1502, C07K 1528, C12P 2108

Patent

active

050734938

ABSTRACT:
Monoclonal antibody NKY13 recognizing sugar chains of mucin-type glycoproteins secreted by cancer cells, for example, the following sugar chains, and hydridoma producing it: ##STR1## The monoclonal antibody NKY13 renders it possible to make highly sensitive judgements in the serodiagnosis of such cancers as colon cancer, stomach cancer and pancreas cancer.

REFERENCES:
Schlorn et al., Cancer Res. 46:3225-28 1986.
Magnani et al., J. Biol. Chem. 257(22):14365-9, 1982.
Fukushi et al., Biochemistry 25:2859-66, 1986.
Wieruszeski et al., Carbohydrate Res. 137:127-38, 1985.
Mansson et al., Biochimica et Biophysicci Acta 834: 110-117, 1985.
Kipps et al., pp. 108.1-108.9 in Weir et al., Eds. "Handbook of Expt'l. Immunology", vol. 4, Blackwell Sci. Publ., 1986.
Brockhaus et al., Vox Sang. 48:34-38, 1985.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Monoclonal antibody NKY13 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibody NKY13, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody NKY13 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-835259

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.